These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12831920)

  • 1. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
    Moore HG; Akhurst T; Larson SM; Minsky BD; Mazumdar M; Guillem JG
    J Am Coll Surg; 2003 Jul; 197(1):22-8. PubMed ID: 12831920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection.
    Even-Sapir E; Parag Y; Lerman H; Gutman M; Levine C; Rabau M; Figer A; Metser U
    Radiology; 2004 Sep; 232(3):815-22. PubMed ID: 15273334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT in the detection of recurrent rectal cancer.
    Kau T; Reinprecht P; Eicher W; Lind P; Starlinger M; Hausegger KA
    Int Surg; 2009; 94(4):315-24. PubMed ID: 20302028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer.
    Bellomi M; Rizzo S; Travaini LL; Bazzi L; Trifirò G; Zampino MG; Radice D; Paganelli G
    Radiol Med; 2007 Aug; 112(5):681-90. PubMed ID: 17657420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
    Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
    J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-operative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer.
    Faneyte IF; Dresen RC; Edelbroek MA; Nieuwenhuijzen GA; Rutten HJ
    Dig Surg; 2008; 25(3):202-7. PubMed ID: 18577865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.
    Plodeck V; Rahbari NN; Weitz J; Radosa CG; Laniado M; Hoffmann RT; Zöphel K; Beuthien-Baumann B; Kotzerke J; van den Hoff J; Platzek I
    Eur Radiol; 2019 Jan; 29(1):422-428. PubMed ID: 29980927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
    Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of the postoperative local recurrence of rectal cancer by FDG-PET--a case report].
    Katsumoto Y; Maruyama N; Nakamura M; Shingai T; Maruyama K; Nakaguchi K; Furukawa J; Okajima S; Sue F; Fukunaga H; Ikenaga M; Sekimoto K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1688-91. PubMed ID: 11708010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.
    Ruby JA; Leibold T; Akhurst TJ; Shia J; Saltz LB; Mazumdar M; Riedel ER; Larson SM; Guillem JG
    Dis Colon Rectum; 2012 Apr; 55(4):378-86. PubMed ID: 22426260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.
    Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK
    J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer.
    Sun SS; Chen TC; Yen RF; Shen YY; Changlai SP; Kao A
    Anticancer Res; 2001; 21(4B):2957-61. PubMed ID: 11712793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
    Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.
    Guillem JG; Moore HG; Akhurst T; Klimstra DS; Ruo L; Mazumdar M; Minsky BD; Saltz L; Wong WD; Larson S
    J Am Coll Surg; 2004 Jul; 199(1):1-7. PubMed ID: 15217621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Kuwano H
    Br J Surg; 2004 Aug; 91(8):1004-9. PubMed ID: 15286962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.
    Nahas CS; Akhurst T; Yeung H; Leibold T; Riedel E; Markowitz AJ; Minsky BD; Paty PB; Weiser MR; Temple LK; Wong WD; Larson SM; Guillem JG
    Ann Surg Oncol; 2008 Mar; 15(3):704-11. PubMed ID: 17882490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
    Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
    J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
    Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer.
    De Potter T; Flamen P; Van Cutsem E; Penninckx F; Filez L; Bormans G; Maes A; Mortelmans L
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):525-9. PubMed ID: 11914891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.